skip to main content

U-M scientists observe deadly dance between nerves and cancer cells

In certain types of cancer, nerves and cancer cells enter an often lethal and intricate waltz where cancer cells and nerves move toward one another and eventually engage in such a way that the cancer cells enter the nerves.

Adrenal Cancer Diagnosis and Staging

Most adrenal cancers have grown for a long time before they are diagnosed. They are often found after the patient seeks treatment for the symptoms caused by the cancer. However, some tumors are found when a physician orders imaging testing for another condition.

Patients with symptoms suspicious for adrenal cancer will undergo tests to determine the cause of these symptoms. The first step is a thorough medical history and physical exam to determine the extent of symptoms and their possible causes.

Multidisciplinary Multiple Myeloma and Plasma Cell Dyscrasias Clinic

The Multidisciplinary Multiple Myeloma and Plasma Cell Dyscrasias Clinic, located at the University of Michigan Rogel Cancer Center, follows a team approach to care. Your first patient visit is with a doctor and nurse who focus exclusively on multiple myeloma care. Contact us: 734-647-8902

What is multiple myeloma?

Multiple myeloma (MM) is a type of blood cancer formed from plasma cells which are a type of white blood cell that lives in the bone marrow. MM is one of several types of plasma cell neoplasms that are diseases in which the body makes too many plasma cells.

Cancer Center surgeon receives campus diversity award

Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125

U-M researchers find new gene involved in blood-forming stem cells

Research has identified a gene critical to controlling the body’s ability to create blood cells and immune cells from blood-forming stem cells, a process critical during bone marrow transplant.

Researchers find protein that may signal more aggressive prostate cancers

University of Michigan researchers have discovered a biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer.

A third of breast cancer patients concerned about genetic risk

A new study finds that many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer.

Panel predicts whether rare leukemia will respond to treatment

Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.

Pages